These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34526431)

  • 1. Soluble LR11 as a Novel Biomarker in Acute Kawasaki Disease.
    Watanabe K; Suzuki H; Jiang M; Tsukano S; Kataoka S; Ito S; Sakai T; Hirokawa T; Haniu H; Numano F; Hoshina S; Hasegawa S; Matsunaga M; Chiba K; Saito N; Yoshida H; Takami S; Okubo S; Hirano H; Saitoh A; Bujo H
    Circ J; 2022 May; 86(6):977-983. PubMed ID: 34526431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble LR11 is a novel biomarker for vascular lesions late after Kawasaki disease.
    Watanabe K; Suzuki H; Jiang M; Haniu H; Numano F; Hoshina S; Saitoh A; Uchiyama M; Bujo H
    Atherosclerosis; 2016 Mar; 246():94-7. PubMed ID: 26761773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
    Iwashima S; Kimura M; Ishikawa T; Ohzeki T
    Clin Drug Investig; 2011; 31(3):191-9. PubMed ID: 21456105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of circulating soluble LR11 on long-term clinical outcomes in patients with coronary artery disease.
    Ogita M; Miyauchi K; Kasai T; Tsuboi S; Wada H; Naito R; Konishi H; Dohi T; Tamura H; Okazaki S; Yanagisawa N; Shimada K; Suwa S; Jiang M; Bujo H; Daida H
    Atherosclerosis; 2016 Jan; 244():216-21. PubMed ID: 26687467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepcidin in Kawasaki disease: upregulation by acute inflammation in patients having resistance to intravenous immunoglobulin therapy.
    Ishikawa T; Wada Y; Namba H; Kawai T
    Clin Rheumatol; 2021 Dec; 40(12):5019-5024. PubMed ID: 34148165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
    Kitoh T; Ohara T; Muto T; Okumura A; Baba R; Koizumi Y; Yamagishi Y; Mikamo H; Daigo K; Hamakubo T
    Front Immunol; 2021; 12():624802. PubMed ID: 33912155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki disease.
    Qi Y; Gong F; Zhang Q; Xie C; Wang W; Fu S
    Arthritis Res Ther; 2012 Nov; 14(6):R251. PubMed ID: 23171632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating soluble form of LR11, a regulator of smooth muscle cell migration, is a novel marker for intima-media thickness of carotid arteries in type 2 diabetes.
    Jin W; Jiang M; Han X; Han X; Murano T; Hiruta N; Ebinuma H; Piao L; Schneider WJ; Bujo H
    Clin Chim Acta; 2016 Jun; 457():137-41. PubMed ID: 27095609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased circulating soluble LR11 in patients with acute coronary syndrome.
    Ogita M; Miyauchi K; Dohi T; Tsuboi S; Miyazaki T; Yokoyama T; Yokoyama K; Shimada K; Kurata T; Jiang M; Bujo H; Daida H
    Clin Chim Acta; 2013 Jan; 415():191-4. PubMed ID: 23127357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of procalcitonin in Kawasaki disease: a useful candidate for differentiating from sepsis and evaluating IVIG responsiveness.
    Niu MM; Jiang Q; Ruan JW; Liu HH; Chen WX; Qiu Z; Fan GZ; Li RX; Wei W; Hu P
    Clin Exp Med; 2021 Nov; 21(4):633-643. PubMed ID: 33839960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ang II-stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice.
    Jiang M; Bujo H; Ohwaki K; Unoki H; Yamazaki H; Kanaki T; Shibasaki M; Azuma K; Harigaya K; Schneider WJ; Saito Y
    J Clin Invest; 2008 Aug; 118(8):2733-46. PubMed ID: 18618022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Levels of Platelet Activating Factor and Its Acetylhydrolase Indicate High Risk of Kawasaki Disease.
    Yi L; Zhang J; Zhong J; Zheng Y
    J Interferon Cytokine Res; 2020 Mar; 40(3):159-167. PubMed ID: 31841639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced circulating soluble LR11 in patients with coronary organic stenosis.
    Takahashi M; Bujo H; Jiang M; Noike H; Saito Y; Shirai K
    Atherosclerosis; 2010 Jun; 210(2):581-4. PubMed ID: 20047743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin (PCT) and Kawasaki Disease: Does PCT Correlate With IVIG-Resistant Disease, Admission to the Intensive Care Unit, or Development of Coronary Artery Lesions?
    Dominguez SR; Martin B; Heizer H; Jone PN; Tong S; Davidson J; Anderson MS; Glodé MP
    J Pediatric Infect Dis Soc; 2016 Sep; 5(3):297-302. PubMed ID: 26407256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of LR11 Attenuates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation With Medial Thickening in Mice.
    Jiang L; Konishi H; Nurwidya F; Satoh K; Takahashi F; Ebinuma H; Fujimura K; Takasu K; Jiang M; Shimokawa H; Bujo H; Daida H
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1972-9. PubMed ID: 27493099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of circulating soluble LR11, a regulator of smooth muscle cell migration, are highly associated with atherosclerotic plaques in patients with carotid artery stenosis.
    Harada M; Jiang M; Terai K; Ebinuma H; Hiruta N; Schneider WJ; Sugo N; Nagao T; Bujo H
    Clin Chim Acta; 2019 Mar; 490():69-76. PubMed ID: 30550937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of the soluble LDL receptor-relative LR11 decrease in overweight individuals with type 2 diabetes upon diet-induced weight loss.
    Berk KA; Vongpromek R; Jiang M; Schneider WJ; Timman R; Verhoeven AJ; Bujo H; Sijbrands EJ; Mulder MT
    Atherosclerosis; 2016 Nov; 254():67-72. PubMed ID: 27697674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an immunoassay for the quantification of soluble LR11, a circulating marker of atherosclerosis.
    Matsuo M; Ebinuma H; Fukamachi I; Jiang M; Bujo H; Saito Y
    Clin Chem; 2009 Oct; 55(10):1801-8. PubMed ID: 19661140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble form of LR11 is highly increased in the vitreous fluids of patients with idiopathic epiretinal membrane.
    Hashimoto R; Jiang M; Shiba T; Hiruta N; Takahashi M; Higashi M; Hori Y; Bujo H; Maeno T
    Graefes Arch Clin Exp Ophthalmol; 2017 May; 255(5):885-891. PubMed ID: 28102455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating soluble LR11/SorLA levels are highly increased and ameliorated by chemotherapy in acute leukemias.
    Sakai S; Nakaseko C; Takeuchi M; Ohwada C; Shimizu N; Tsukamoto S; Kawaguchi T; Jiang M; Sato Y; Ebinuma H; Yokote K; Iwama A; Fukamachi I; Schneider WJ; Saito Y; Bujo H
    Clin Chim Acta; 2012 Oct; 413(19-20):1542-8. PubMed ID: 22750733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.